1. Home
  2. LXRX vs TEAD Comparison

LXRX vs TEAD Comparison

Compare LXRX & TEAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • TEAD
  • Stock Information
  • Founded
  • LXRX 1995
  • TEAD 2006
  • Country
  • LXRX United States
  • TEAD United States
  • Employees
  • LXRX N/A
  • TEAD N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • TEAD
  • Sector
  • LXRX Health Care
  • TEAD
  • Exchange
  • LXRX Nasdaq
  • TEAD NYSE
  • Market Cap
  • LXRX 228.8M
  • TEAD 241.4M
  • IPO Year
  • LXRX 2000
  • TEAD N/A
  • Fundamental
  • Price
  • LXRX $1.08
  • TEAD $2.57
  • Analyst Decision
  • LXRX Buy
  • TEAD
  • Analyst Count
  • LXRX 4
  • TEAD 0
  • Target Price
  • LXRX $3.67
  • TEAD N/A
  • AVG Volume (30 Days)
  • LXRX 5.0M
  • TEAD 396.3K
  • Earning Date
  • LXRX 07-31-2025
  • TEAD 08-16-2025
  • Dividend Yield
  • LXRX N/A
  • TEAD N/A
  • EPS Growth
  • LXRX N/A
  • TEAD N/A
  • EPS
  • LXRX N/A
  • TEAD N/A
  • Revenue
  • LXRX $31,213,000.00
  • TEAD $959,268,000.00
  • Revenue This Year
  • LXRX N/A
  • TEAD $65.64
  • Revenue Next Year
  • LXRX N/A
  • TEAD $5.29
  • P/E Ratio
  • LXRX N/A
  • TEAD N/A
  • Revenue Growth
  • LXRX 1251.21
  • TEAD 4.15
  • 52 Week Low
  • LXRX $0.28
  • TEAD $2.32
  • 52 Week High
  • LXRX $2.45
  • TEAD $7.87
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 66.94
  • TEAD N/A
  • Support Level
  • LXRX $0.84
  • TEAD N/A
  • Resistance Level
  • LXRX $1.19
  • TEAD N/A
  • Average True Range (ATR)
  • LXRX 0.09
  • TEAD 0.00
  • MACD
  • LXRX 0.02
  • TEAD 0.00
  • Stochastic Oscillator
  • LXRX 76.60
  • TEAD 0.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About TEAD TEADS HLDG CO

Teads Holding Co is the omnichannel outcomes platform for the open internet, driving full-funnel results for marketers across premium media. Its Focus on meaningful business outcomes for branding and performance objectives, the combined company ensures value is driven with every media dollar by leveraging predictive AI technology to connect quality media, beautiful brand creative, and context-driven addressability and measurement.

Share on Social Networks: